Independent advising for practices and mid-size healthcare organizations in Nashville and surrounding areas. We say whether AI is justified—even when the answer is no. We do not sell software.
Fixed-fee engagements scoped to the decision your organization needs.
A short diagnostic for practices that need a fast and honest answer.
You walk away with: a written recommendation and next-step options.
Start with Discovery
Prioritized opportunities by impact, effort, and financial feasibility.
You walk away with: a 90-day action plan—or a clear case to pause.
Start with Root Assessment
Support only after a documented business case. Typically $18,000–$48,000.
You walk away with: scoped delivery or ongoing independent advisory.
Discuss a projectIf AI is not the right answer, we say so in writing. Fees are fixed. We sell no software and take no commission on tools. You pay for clarity—not a product demo.
Leaders need a clear AI decision before capital is committed—not another product demonstration.
We sell no software, take no commissions, and have no preferred partners. Recommendations rest only on your operational constraints and objectives.
We recommend AI only when the expected benefit outweighs cost, risk, and change effort. When it does not, we say so clearly.
Investment and deliverables are defined before work begins. This structure serves practices and mid-size organizations that need budget predictability.
We help healthcare organizations invest in AI only when it is practical, financially justified, and aligned with real operational need—guided by honesty, integrity, and vendor-neutral judgment.
A simple, high-level path—without giving away proprietary details.
Understand the workflow, the constraints, and what “better” would mean in measurable terms.
Check whether AI is the right lever—or whether a process change, staffing adjustment, or simpler tool fits better.
Recommend go, no-go, or a staged path so capital is committed only when the case holds.
Independent reporting shows that buying or building the wrong AI capability often produces spend without return. Feasibility first is how organizations avoid that pattern.
MIT NANDA’s State of AI in Business 2025 found that despite an estimated $30–40 billion in enterprise generative-AI spend, 95% of pilots delivered no measurable profit-and-loss impact. The typical failure was not the model; it was the selection of use cases that never connected to a real workflow or financial outcome.1
Olive sold hospitals an “AI workforce” for revenue-cycle and administrative work, reached a $4 billion valuation, then shut down after hospitals reported inconsistent delivery and weak returns. Rapid scale without a proven savings case left buyers with implementation cost and no durable benefit.2
A University of Texas System audit found MD Anderson spent $62.1 million on an IBM Watson oncology project that never treated a patient. The institution later ended the collaboration. The cost was real; the clinical and financial return was not.3
Figures are summarized from public research and reporting for educational purposes. Individual results vary. Blue Pear Tree is not affiliated with the cited organizations. This section is not legal or investment advice.
Book a free 15-minute fit call. We focus on your operational challenges—not a product demo.
Book a free fit callIndependent advising grounded in operational discipline—not product distribution.
Blue Pear Tree is led by a principal advisor with a B.S. in Biology, industrial engineering credentials, and an Executive MBA. Process-improvement work across Fortune companies informs every engagement: map the workflow, measure what matters, then evaluate AI.
We serve independent practices and mid-size healthcare organizations across Nashville and surrounding areas. Fixed-fee work is scoped to the decision required.
Recommendations align with HIPAA expectations and the NIST AI Risk Management Framework. We do not provide legal advice or certification services.
Most clients move from a fit call to decision support within three weeks. The process is built for healthcare—not generic AI.
Document operational challenges, constraints, and priorities. This step typically takes one to three days.
You walk away with: a shared problem statement and decision scope.
Map workflows, assess AI suitability, and weigh cost, effort, and risk together.
You walk away with: ranked options and a feasibility view.
Deliver clear findings: a prioritized plan when AI fits—or a written no-go when it does not.
You walk away with: a defined recommendation and next steps.
No. Blue Pear Tree is vendor-neutral. We do not sell software, accept referral fees, or promote preferred tools. Our role is strictly independent advisory work.
Independent practices and mid-size healthcare organizations in Nashville and surrounding areas that need a clear decision on AI before investment—especially for documentation burden, prior authorization, staffing, or workflow efficiency.
Discovery Scan: $1,800–$2,800. Root Assessment: $5,000–$9,500. Projects are scoped on a fixed-fee basis (typically $18,000–$48,000). All fees are confirmed in writing before work begins.
We state the recommendation clearly. In some cases, a process change or a simpler tool is the better path. You still receive a defined recommendation and next steps.
After an initial consultation, Discovery Scans are typically completed in three to five business days. Root Assessments are generally completed within one to three weeks.
Published cases show that the cost of a poor fit can exceed any promised savings—from enterprise GenAI pilots with no P&L impact to healthcare projects that spent tens of millions without treating a patient. An independent feasibility review is designed to prevent that spend. See published evidence.
A short 15-minute conversation to confirm whether an engagement is useful. There is no product pitch. If we are not the right fit, we will say so.
Use the form below or email info@bluepeartree.com. We respond within one business day.
Tell us the operational challenge or decision under consideration. We respond within one business day with a focused discussion—not a product pitch. Most first conversations are a free 15-minute fit call.